Lucena-Cacace et al. demonstrated that elevated NAD+ levels are associated with increased nicotinamide phosphoribosyltransferase (NAMPT) activity, which correlates with tumor progression and a poor prognosis [12]. Here, NAMPT is linked to neoplasm.